Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-03
2007-04-03
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S229000
Reexamination Certificate
active
10505902
ABSTRACT:
Compounds of the formula (I), or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof,wherein —N-HET is, for example, (Ic) or (If)wherein R1 is, for example, halogen or a (1–4C)alkyl group which is substituted by one substituent selected from, for example, hydroxy, (1–4C)alkoxy, amino, cyano or azido; Q is selected from, for example, Q1wherein R2and R3are independently hydrogen or fluoro;T is selected from a range of groups, for example,wherein m is 0, 1 or 2; are useful as antibacterial agents; and processes for their manufacture and pharmaceutical compositions containing them are described.
REFERENCES:
patent: 6028090 (2000-02-01), Gante et al.
patent: 0 184 170 (1985-11-01), None
patent: WO-95/07271 (1995-03-01), None
patent: WO-97/14690 (1997-04-01), None
patent: WO-97/27188 (1997-07-01), None
patent: WO-97/30995 (1997-08-01), None
patent: WO-97/31917 (1997-09-01), None
patent: WO-97/43280 (1997-11-01), None
patent: WO-98/01446 (1998-01-01), None
patent: WO-98/01447 (1998-01-01), None
patent: WO-99/10342 (1999-03-01), None
patent: WO 99/10343 (1999-03-01), None
patent: WO-99/11642 (1999-03-01), None
patent: WO-99/28317 (1999-06-01), None
patent: WO-99/64416 (1999-12-01), None
patent: WO-99/64417 (1999-12-01), None
patent: WO-00/21960 (2000-04-01), None
patent: WO-01/40222 (2001-06-01), None
patent: WO-01/40236 (2001-06-01), None
patent: WO-01/58885 (2001-08-01), None
patent: WO-01/81350 (2001-11-01), None
patent: WO-02/080841 (2002-10-01), None
patent: WO-02/081468 (2002-10-01), None
patent: WO-02/081469 (2002-10-01), None
patent: WO-02/081470 (2002-10-01), None
patent: WO-02/036917 (2002-12-01), None
patent: WO-02/096890 (2002-12-01), None
patent: WO-02/096916 (2002-12-01), None
patent: WO-02/096918 (2002-12-01), None
patent: WO-03/022824 (2003-03-01), None
patent: WO-03/022840 (2003-03-01), None
patent: WO-03/035073 (2003-05-01), None
patent: WO-03/035648 (2003-05-01), None
patent: WO-2004/048350 (2004-06-01), None
patent: WO-2004/048370 (2004-06-01), None
patent: WO-2004/048392 (2004-06-01), None
patent: WO-2004/056816 (2004-07-01), None
patent: WO-2004/056817 (2004-07-01), None
patent: WO-2004/056818 (2004-07-01), None
patent: WO-2004/056819 (2004-07-01), None
patent: WO-2004/078753 (2004-09-01), None
patent: WO-2004/083205 (2004-09-01), None
patent: WO-2004/083206 (2004-09-01), None
Bundgaard, H., “Design of prodrugs: Bioreversible derivatives for various functional groups and chemical entities”, In Design of Pro-drugs, Bundgaard, H., eds. (Elsevier Science Publishers B.V.), pp. 1-92 (1985).
Gregory, W.A., et al., “Antibacterials. Synthesis and Structure-Activity Studies of 3-Aryl-2-oxooxazolidines. 1. The “B” Group,” J. Med. Chem., 32:1673-1681 (1989).
Phillips, O.A., et al., “Synthesis and Antibacterial Activity of 5-Substituted Oxazolidinones,” Bioorganic & Medicinal Chemistry, 11:35-41 (2003).
Reck, F., et al., “Novel (5R)-1,2,3-Triazolylmethyl Oxazolidinones: 4-Substituted 1,2,3-Triazoles as Antibacterial Agents with Reduced Activity against Monoamine Oxidase A,” Poster at ICAAC 2004.
Carcanague Daniel Robert
Fleming Paul Robert
Gravestock Michael Barry
Hales Neil James
Reck Folkert
AstraZeneca AB
Freistein Andrew B.
McKane Joseph K.
LandOfFree
Chemical compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemical compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemical compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3769748